Carasent - Public Comps and Valuation Multiples

Carasent Overview

About Carasent

Carasent AB (publ) Formerly Carasent AB is in the businesses that develop entrepreneurial and e-health solutions. It delivers cloud based EHR solutions, with Webdoc as the platform, and a ecosystem of platform services, including solutions for patient communication and business intelligence. The ecosystem of solutions makes Carasent a one-stop shop for clinics and can cover all needs.

Founded

1997

HQ

Employees

165

Website

carasent.com

Sectors

Healthcare Software
B2B SaaS
Vertical SaaS
HealthTech

Financials

LTM Revenue $34.7M

LTM EBITDA $7.0M

EV

$182M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Carasent Financials

As of September 2025, Carasent reported last 12-month revenue of $34.7M and EBITDA of $7.0M.

In the same period, Carasent generated $29.4M in LTM gross profit and -$0.1M in net income.

See Carasent valuation multiples based on analyst estimates

Carasent P&L

In the most recent fiscal year, Carasent reported revenue of $29.0M and EBITDA of $1.8M.

Carasent expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Carasent valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$34.7M	XXX	$29.0M	XXX	XXX	XXX
Gross Profit	$29.4M	XXX	$24.5M	XXX	XXX	XXX
Gross Margin	85%	XXX	85%	XXX	XXX	XXX
EBITDA	$7.0M	XXX	$1.8M	XXX	XXX	XXX
EBITDA Margin	20%	XXX	6%	XXX	XXX	XXX
EBIT	-$0.1M	XXX	-$5.2M	XXX	XXX	XXX
EBIT Margin	0%	XXX	-18%	XXX	XXX	XXX
Net Profit	-$0.1M	XXX	-$4.4M	XXX	XXX	XXX
Net Margin	0%	XXX	-15%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Carasent including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $34.7M. EBITDA for the last twelve months was $7.0M. In the most recent fiscal year, Carasent achieved $29.0M in revenue and $1.8M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$34.7M	Analyst estimates available to subscribers	$29.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$29.4M	Analyst estimates available to subscribers	$24.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	84.8% gross margin	Analyst estimates available to subscribers	84.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$7.0M	Analyst estimates available to subscribers	$1.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	20.2% EBITDA margin	Analyst estimates available to subscribers	6.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$0.1M	Analyst estimates available to subscribers	-$5.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-0.3% EBIT margin	Analyst estimates available to subscribers	-18.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$0.1M	Analyst estimates available to subscribers	-$4.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-0.2% net profit margin	Analyst estimates available to subscribers	-15.4% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Carasent

This financial data table provides comprehensive performance metrics for Carasent, a company based in Sweden. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Carasent generated $34.7M in revenue over the last twelve months.
The company achieved $7.0M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $29.4M.
Net income over the last twelve months reached -$0.1M.

Fiscal Year Performance

In the most recent fiscal year, Carasent reported $29.0M in total revenue.
Fiscal year EBITDA was $1.8M.
The company maintained a gross profit margin of 84.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 6.4%.
Net profit margin reached -15.4% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Carasent. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Carasent Stock Performance

Carasent has current market cap of SEK 1.9B (or $196M), and EV of SEK 1.7B (or $182M).

Market Cap Evolution

Carasent Stock Data

As of October 17, 2025, Carasent's stock price is SEK 27 (or $3).

See Carasent trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$182M	$196M	XXX	XXX	XXX	XXX	$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Carasent Valuation Multiples

Carasent's trades at 6.3x EV/Revenue multiple, and 98.7x EV/EBITDA.

See valuation multiples for Carasent and 15K+ public comps

Carasent Financial Valuation Multiples

As of October 17, 2025, Carasent has market cap of $196M and EV of $182M.

Equity research analysts estimate Carasent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Carasent has a P/E ratio of -2363.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$196M	XXX	$196M	XXX	XXX	XXX
EV (current)	$182M	XXX	$182M	XXX	XXX	XXX
EV/Revenue	5.2x	XXX	6.3x	XXX	XXX	XXX
EV/EBITDA	26.0x	XXX	98.7x	XXX	XXX	XXX
EV/EBIT	-1743.3x	XXX	-35.0x	XXX	XXX	XXX
EV/Gross Profit	6.2x	XXX	n/a	XXX	XXX	XXX
P/E	-2363.1x	XXX	-44.2x	XXX	XXX	XXX
EV/FCF	-665.4x	XXX	-335.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Carasent Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Carasent Margins & Growth Rates

Carasent's last 12 month revenue growth is 18%

Carasent's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Carasent's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Carasent's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Carasent and other 15K+ public comps

Carasent Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	18%	XXX	21%	XXX	XXX	XXX
EBITDA Margin	20%	XXX	6%	XXX	XXX	XXX
EBITDA Growth	60%	XXX	405%	XXX	XXX	XXX
Rule of 40	19%	XXX	24%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	65%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	102%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial